ARCHIVES

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014

In Brief: Lucius Sinks New Cancer Centers Branch Chief; Mary Sears, One Of ASCO Founders, to Retire

May 11, 1984

Komen Under Pressure: Charity Faces Money Woes, Attacks from Right

October 26, 2012

Ontak Approved For Lymphoma

October 31, 2008

“Comprehensive” Tag For Centers A Poor Choice, Word-Conscious NCI Staff, Committee Feel

February 22, 1974

ACS Plans 7 Hearings Around U.S. On cancer In The Disadvantaged

April 7, 1989